CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-20 | HULL ANDREW Director | Grant or award · Employee Stock Option (Right to Buy) | +550 | 977 | ||
| 2024-07-31 | MANCINI ALEXANDRA DIANE JANET Consultant | Sale | −240 | $0.18 | $42 | 0 |
| 2024-05-27 | WOUDENBERG MICHAEL Chief Operating Officer | Other disposition · Employee Stock Option (Expiration) | −394 | 75,100 | ||
| 2024-05-27 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −545 | 52,000 | ||
| 2024-05-27 | ADAMS ERIC A President & CEO | Other disposition · Employee Stock Option (Expiration) | −1,139 | 161,000 | ||
| 2024-05-27 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −485 | 52,000 | ||
| 2024-03-04 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −309 | 52,545 | ||
| 2024-02-21 | HULL ANDREW Director | Purchase | +37,500 | $0.39 | $15K | 38,258 |
| 2024-02-20 | ADAMS ERIC A President & CEO | Purchase | +41,600 | $0.36 | $15K | 43,959 |
| 2024-01-21 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −121 | 52,485 | ||
| 2024-01-14 | HULL ANDREW Director | Other disposition · Employee Stock Option (Expiration) | −42 | 8,542 | ||
| 2023-12-23 | Johnson Shane Aaron Sr VP & General Manager | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 48,000 | ||
| 2023-12-23 | Lemerond Nicole Director | Grant or award · Employee Stock Option (Right to Buy) | +7,100 | 8,500 | ||
| 2023-12-23 | WOUDENBERG MICHAEL Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 75,494 | ||
| 2023-12-23 | Tegge Jonathan Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 31,400 | ||
| 2023-12-23 | Grove Janet P Director | Grant or award · Employee Stock Option (Right to Buy) | +7,100 | 8,500 | ||
| 2023-12-23 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Grant or award · Employee Stock Option (Right to Buy) | +45,000 | 52,854 | ||
| 2023-12-23 | ADAMS ERIC A President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +136,000 | 162,139 | ||
| 2023-12-23 | Baldasare Bryan T Director | Grant or award · Employee Stock Option (Right to Buy) | +7,100 | 8,500 | ||
| 2023-12-23 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Grant or award · Employee Stock Option (Right to Buy) | +45,000 | 52,606 |
Page 5 of 8 · 149 trades